Company | Name | Exchange | Sector | Industry | Analyst Recommendation | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSL | Sydney | Healthcare | Pharmaceuticals | 1.53 | $117.13B | 26.9x | 2.41 | $241.89 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.2% Upside | Upgrade to Pro+ | |
Resmed DRC | Sydney | Healthcare | Healthcare Equipment & Supplies | 1.69 | $54.17B | 24.1x | 0.62 | $36.08 | 8.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.7% Upside | Upgrade to Pro+ | |
Regis Healthcare Ltd | Sydney | Healthcare | Healthcare Providers & Services | 1.71 | $2.03B | 128.3x | 0.66 | $6.75 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.6% Upside | Upgrade to Pro+ | |
Polynovo | Sydney | Healthcare | Healthcare Equipment & Supplies | 2.11 | $808.29M | 117.3x | 0.49 | $1.17 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Australian Clinical Labs | Sydney | Healthcare | Healthcare Providers & Services | 2.13 | $593.34M | 19.5x | 0.19 | $3.01 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.2% Upside | Upgrade to Pro+ |